PT Kino Indonesia Tbk (KINO) Fair Value & Analysis
Consumer Defensive · ID · Market cap 1.6T IDR
Fair value as of: Jul 18, 2026
From 25 valuation models · updated 23 days ago
Fair value updated Jul 18, 2026, revised from 1,884 IDR to 1,563 IDR (−17.1%) since Jun 24, 2026. Share price +16.6% over the past month.
A solid business, screening 20% undervalued on our models.
What matters now
- Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (1,144 IDR to 2,214 IDR) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
60‑month range 942.97 IDR – 4,716 IDR · fair‑value band 1,144 IDR – 2,214 IDR · the 1,300 IDR price screens below the 1,563 IDR fair value. Dashed = 300-day average. As of Jul 18, 2026.
Analysis
PT Kino Indonesia Tbk (KINO) currently trades at 1,300 IDR, while our model-based Fair Value estimate is 1,563 IDR, implying the stock looks roughly 20.2% undervalued today. The Quality Score stands at 56/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, PT Kino Indonesia Tbk generated revenue of 4.6T IDR at a net margin of 3.3%. Revenue grew 11.4% year over year. It earns a return on equity of 8.6%. Net debt stands at 1.4T IDR. Fundamentals as of Jul 18, 2026
Our scenario range runs from 1,144 IDR (bear case) to 2,214 IDR (bull case); at 1,300 IDR, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 8% below its 52-week high and 34% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at 20%, KINO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 25 models by family
Widest divergence: DCF Models (2,463 IDR) versus Dividend Discount (469.86 IDR). Highest evidence: Growth DCF (80).
Notify me when KINO reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 64
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Kino Indonesia Tbk produces and sells personal care, beverages, food, pharmaceutical, and pet food products in Indonesia and internationally.
Full company description
PT Kino Indonesia Tbk produces and sells personal care, beverages, food, pharmaceutical, and pet food products in Indonesia and internationally. It offers personal care products under the Ellips, Sleek Baby, Oval, Eskulin, Samantha, Sasha, Master, Abstract, Sasha Halal Toothpaste, Ristra, Eskulin Kids, Master Kids, B&B, Resik V, Absolute, and Click brands; beverages under the Cap Panda, Cap Kaki Tiga, Panther, Malee, Segar Sari, and Cap Kaki Tiga Anak brands; food under the Kino Candy Chewey, Snack It Marshmallow, PIA 100, Chew Chew Ball, and Kino Nastar brands; home care products under the Sleek and Instance hand sanitizer brands; health and wellness products under the Ristra Clinic and Cap Kaki Tiga Pharma brands; and pet care products under the MAXlife, Perro, KUCINGKU, and JOJO brand names. The company was formerly known as PT Kinocare Era Kosmetindo. PT Kino Indonesia Tbk was incorporated in 1999 and is headquartered in Tangerang, Indonesia. PT Kino Indonesia Tbk operates as a subsidiary of PT Kino Investindo.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Kino Indonesia Tbk reported revenue of 4.4T IDR in FY2025 versus 4.0T IDR in FY2021, a compound +2.7%/yr. Reported net income was 124B IDR in FY2025, compounding +4.2%/yr from FY2021.
of which total revenue +2.4 pp · buybacks/dilution −2.0 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch KINO: get an alert when its fair value changes →
Peer Group
Beverages - Non-Alcoholic · 92 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Beverages - Non-Alcoholic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company KO | $87.05 | $36.57 | -58% |
| PepsiCo, Inc PEP | $139.02 | $106.91 | -23% |
| Monster Beverage Corporation MNST | $97.50 | $35.82 | -63% |
| Nongfu Spring Co 9633 | HK$41.44 | HK$30.72 | -26% |
| Coca-Cola Europacific Partners PLC CCEP | €92.10 | €85.41 | -7% |
| Keurig Dr Pepper Inc KDP | $31.25 | $30.99 | -1% |
| Coca-Cola FEMSA, S.A. KOF | $102.04 | $106.45 | +4% |
| Coca-Cola HBC AG EEE | €57.90 | €52.82 | -9% |
| Varun Beverages Limited VBL | ₹495.70 | ₹187.49 | -62% |
| Eastroc Beverage (Group) Co 605499 | ¥124.43 | ¥107.57 | -14% |
Compare PT Kino Indonesia Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is PT Kino Indonesia Tbk (KINO) overvalued or undervalued?
What is the fair value of KINO?
What is the quality score of KINO?
What is the revenue of PT Kino Indonesia Tbk (KINO)?
What is the net profit margin of KINO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Kino Indonesia Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.